Developing Animal Free Organoid Models for Drug Discovery Drug Discovery

Developing Animal Free Organoid Models for Drug Discovery

By Aline F. Miller, The University of Manchester, Professor of Biomolecular Engineering

Innovative Technologies Accelerating First-In-Human to Proof-of-Concept Drug Discovery

Innovative Technologies Accelerating First-In-Human to Proof...

By Aernout van Haarst, Celerion, Director, Scientific Affairs, & Sabina Paglialunga, Director, Scientif...

The Role of Digital Therapeutics in Workplace Mental Health: A Research-Driven Approach CRO

The Role of Digital Therapeutics in Workplace Mental Health:...

By Dr. Brian Alman, True Sage, Founder, Clinical Director and CEO

The AI Revolution in Clinical Trials – Why CROs Need an AI Strategy Now CRO

The AI Revolution in Clinical Trials – Why CROs Need an AI S...

By Dr. Andree Bates, Eularis, Chairman/Founder/CEO/Artificial Intelligence in Pharma Expert

TaBlitz: A new tablet design software that strives for patient centric drug product design CRO

TaBlitz: A new tablet design software that strives for patie...

By Nelio Drumond, Takeda Pharmaceutical Company Limited, Associate Director, Lead Process Scientist

The future of drug discovery, testing with computational models and Artificial Intelligence CRO

The future of drug discovery, testing with computational mod...

By Jana Brajdih Cendak, Billev Pharma East, Medical and Pharmacovigilance Lead/Medical Advisor/EU QPPV

The Benefits of Data Analytics in Compliance: Design, Effectiveness and Company Culture Compliance

The Benefits of Data Analytics in Compliance: Design, Effect...

By Phillip Macmillan, Forensic Risk Alliance, Director, & Sharon Hall, Director

Supply and distribution agreements: make the most of it by June! Compliance

Supply and distribution agreements: make the most of it by J...

By Natasha Tardif, Reed Smith, Competition & Regulatory dept and Managing Partner, & Audrey Augusto, Se...

Fintechs Will Be Doomed to Repeat History Unless They Learn From It Compliance

Fintechs Will Be Doomed to Repeat History Unless They Learn...

By Brian Tate, Innovative Payments Association, President & CEO

Establishing a Global Code of Conduct That Resonates with Employees Compliance

Establishing a Global Code of Conduct That Resonates with Em...

By Patricia Colombo, FUJIFILM Holdings America Corporation, Chief Compliance Officer

How Digital Opinion Leaders Are Transforming Clinical Trial Awareness Clinical Trial Management

How Digital Opinion Leaders Are Transforming Clinical Trial...

By Sandra Shpilberg, Adnexi, Co-Founder & CEO

Redesigning the Clinical Trial Table: Who’s Missing, Who’s Leading, and What Comes Next Clinical Trial Management

Redesigning the Clinical Trial Table: Who’s Missing, Who’s L...

By Maimah Karmo, Tigerlily Foundation, President

Beyond Borders: Cost Optimization Strategies in Multi-Country Clinical Trials Clinical Trial Management

Beyond Borders: Cost Optimization Strategies in Multi-Countr...

By Niranjan Andhalkar, ProRelix Research, Director- Strategic Management & Planning

The Changing CRO Environment: Responding to New Models of Service Delivery and Change CRO

The Changing CRO Environment: Responding to New Models of Se...

By Dr. Diana L. Foster, Total Diversity Clinical Trial Management, CEO

Why CROs Are Still Losing the Recruitment Battle – And What Comes Next CRO

Why CROs Are Still Losing the Recruitment Battle – And What...

By Rose Wang, 1104Health, Founder & CEO

Navigating Innovation and Complexity: Trends Shaping the Future of Veterinary CROs CRO

Navigating Innovation and Complexity: Trends Shaping the Fut...

By Poala Anfossi, Vetspin, General Manager

Lifescience Market Review

Creating quality content that help to improve your business is at the heart of what EV is. We aim provide a comprehensive platform that support the growth of young and ambitious entrepreneurs through unique insights and valuable networks